)
Edge14 Aug 2026
Deutsche Qualität: The Story of Birkenstock
From an 18th-century German shoemaker to a global footwear brand, how Birkenstock turned an orthopedic insole into the world's most popular sandal.
Jubilant Ingrevia
Jubilant Ingrevia (JUBLINGREA) investor relations material
Jubilant Ingrevia Q1 26/27 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q1 26/27 earnings summary23 Jul, 2026
Executive summary
Q1 FY27 delivered strong financial performance with consolidated revenue reaching ₹1,300 crore, up 25% year-over-year, and EBITDA up 37% year-over-year, marking a 15-quarter high and robust operational execution despite global supply chain disruptions.
Growth was broad-based across Specialty Chemicals, Nutrition, and Chemical Intermediates, with Pharmaceuticals and Agrochemicals showing resilient demand and healthy export visibility.
The company advanced strategic priorities, expanding its CDMO and fine chemicals pipeline, completed the integration of Remidex Pharma, and maintained global leadership in core products.
Net profit for the quarter was ₹10,582 lakhs, up from ₹7,510 lakhs year-over-year and ₹8,644 lakhs sequentially.
The company expanded its customer base, especially in electronics/semiconductor and cosmetics.
Financial highlights
Revenue reached ₹1,300 crore, up 25% year-over-year and 10% sequentially; EBITDA at ₹209 crore, up 37% year-over-year and 22% quarter-on-quarter; PAT at ₹106 crore, up 41% year-over-year and 22% quarter-on-quarter.
Specialty Chemicals revenue was ₹533 crore (+11% YoY), Nutrition & Health revenue ₹243 crore (+36% YoY), Chemical Intermediates revenue ₹524 crore (+38% YoY).
EBITDA margin improved to 16%, PAT margin at 8%, and EPS was ₹6.7, up 41% YoY.
Operating margin was 11.39% (up from 9.76% YoY); net profit margin improved to 8.07% from 7.16% YoY.
Debt service coverage ratio stood at 4.81 times, and interest service coverage ratio at 12.01 times.
Outlook and guidance
Sequential improvement in revenue and EBITDA expected in coming quarters, led by Specialty Chemicals and Nutrition, with recovery in acetyls.
FY27 EBITDA guidance maintained at ₹750–800 crore, with first half expected to deliver ₹400+ crore.
New multipurpose plant on track for commissioning by year-end, supporting CDMO and fine chemicals growth.
The group is monitoring the impact of the newly notified Code of Wages (Central) Rules, 2026, and will update accounting as needed.
Why did Speciality Chemicals margins contract?
Analyze Chemical Intermediates profit turnaround
Impact of May 2026 Labour Code Rules notification
Status of semiconductor R&D lab and clean room
Impact of Vitamin B3 pricing on Nutrition EBITDA
Sustainability of Acetic Anhydride realizations
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Jubilant Ingrevia
- Record Q4 revenue and EBITDA, strong specialty and nutrition growth, and robust FY27 outlook.JUBLINGREA
Q4 25/26 - Volume and EBITDA growth offset pricing headwinds; net debt down 20% YoY.JUBLINGREAQ3 25/26
- Record revenue and profit growth in Q2 FY26, led by specialty chemicals and strong margins.JUBLINGREAQ2 25/26
- Specialty chemicals and cost savings drove EBITDA growth, but margin and revenue pressures persist.JUBLINGREAQ1 24/25
- Q2 FY25 saw strong growth, margin gains, major CDMO wins, and digital transformation leadership.JUBLINGREAQ2 24/25
- Specialty chemicals and nutrition drove robust Q3 growth, with EBITDA up 42% year-on-year.JUBLINGREAQ3 24/25
- PAT up 153% YoY, margins and dividend at multi-year highs, driven by specialty and nutrition.JUBLINGREAQ4 24/25
- EBITDA and PAT surged year-on-year, driven by Specialty, Nutrition, and cost initiatives.JUBLINGREAQ1 25/26
Next Jubilant Ingrevia earnings date
Q2 26/2727 Oct, 2026
Jubilant Ingrevia
Next Jubilant Ingrevia earnings date
Q2 26/2727 Oct, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage